At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09637 ALEBUND-B
Market Closed 10-16 16:08:14
17.480
-1.140
-6.12%
High19.630
Low16.890
Vol1.87M
Open19.000
D1 Closing18.620
Amplitude14.72%
Mkt Cap6.08B
Tradable Cap4.13B
Total Shares348.00M
T/O33.98M
T/O Rate0.79%
Tradable Shares236.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
AleBund-B Shares Jump Nearly 7% in Early Trading as Institution Says AP308 Could Unlock a Broader IgA Nephropathy Market
Hong Kong Stock Market Alert | ALEBUND-B (09637) Surges Over 6% on Stock Connect Inclusion and Index Membership, Mircera Sales Jump Approximately 105% Boosting Commercial Momentum
Hong Kong Stock Alert | ALEBUND-B (09637) Surges Over 6% on Dual Catalysts of Index Inclusion and Earnings, with Mircera Commercialization Poised for Growth
Alebund Pharmaceuticals (Jiangsu) Ltd is a China-based company principally engaged in biopharmaceutical business. The Company’s product portfolio in clinical and preclinical stages consists of one core product AP301 and other product candidates, including one late-clinical-stage product candidate AP306, one early-clinical-stage product candidate (AP303), and four preclinical product candidates (AP308, AP304, AP305, and AP307). The Company mainly operates its businesses in the domestic market and overseas markets.